TRIM14 inhibitors are compounds designed to modulate the activity of the TRIM14 protein, a member of the tripartite motif (TRIM) family. The TRIM family is composed of proteins that typically contain a RING-finger domain, one or two B-box domains, and a coiled-coil region, all of which are involved in protein-protein interactions, ubiquitination, and other cellular processes. TRIM14 itself is distinct from many other TRIM family members as it lacks the RING-finger domain typically associated with E3 ubiquitin ligase activity, yet it plays a significant role in regulating intracellular signaling pathways. TRIM14 interacts with multiple partners within the cell, such as other proteins involved in immune response and cellular homeostasis, influencing processes like autophagy, signal transduction, and protein degradation. Because of these regulatory roles, targeting TRIM14 function with inhibitors becomes an area of interest to explore how cellular pathways might be modulated.
Inhibitors of TRIM14 are molecules that bind to this protein, disrupting its interaction with other cellular components or preventing its functional activity in cellular processes. These inhibitors may function by direct binding to the protein, thus altering its conformation or stability, or by targeting co-factors essential to its activity. By inhibiting TRIM14, researchers can study how it influences cellular processes such as protein turnover, immune signaling, and intracellular degradation pathways. TRIM14 inhibitors are valuable tools for dissecting the biological mechanisms that govern cellular responses to stress and environmental stimuli. Furthermore, they enable deeper investigations into the structural and functional dynamics of the TRIM protein family as a whole, particularly in understanding how TRIM14 selectively influences pathways without ubiquitination activity. The development and study of these inhibitors provide insight into TRIM14's broader role within the regulatory networks of the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that can increase cellular levels of TRIM14 by preventing its degradation. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
A known autophagy inhibitor that can modulate the degradation pathways with which TRIM14 may interact. | ||||||
NFκB Activation Inhibitor II, JSH-23 | 749886-87-1 | sc-222061 sc-222061C sc-222061A sc-222061B | 5 mg 10 mg 50 mg 100 mg | $210.00 $252.00 $1740.00 $1964.00 | 34 | |
An NF-kB inhibitor that could alter the transcriptional regulation of TRIM14. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
Another NF-kB pathway inhibitor that may affect TRIM14 expression due to its role in immune signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that could influence the signaling pathways associated with TRIM14's function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor that might modify the cellular response to stress and inflammation, affecting TRIM14. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that can alter multiple signaling pathways, potentially impacting TRIM14 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Another PI3K inhibitor that could have a similar effect as LY294002 on TRIM14. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that can affect protein synthesis and degradation pathways, possibly influencing TRIM14 levels. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
An inhibitor of vacuolar-type H+-ATPase that can interfere with lysosomal acidification and potentially affect TRIM14-related processes. | ||||||